Needham & Company
-
TScan Therapeutics, Inc (TCRX) Announces Pricing of Upsized $150 Million Public Offering
-
TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
-
TScan Therapeutics (TCRX) Launches $125 Million Proposed Public Offering of Common Stock, Warrants
-
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
-
TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference

